CMO Draft Guidance Overly Prescriptive, Out Of Touch – Industry
This article was originally published in The Rose Sheet
PCPC and other trade groups, as well as firms including Pfizer and Merck, say FDA’s draft guidance on quality agreements between drug contract manufacturers and marketers goes into excessive detail and is inconsistent with actual business arrangements common in the industry.
You may also be interested in...
W3ll People is expected to add a relatively modest $7m to e.l.f. Beauty’s fiscal 2021 top line, but the brand has “major white space” opportunities, including at Target, e.l.f.’s longest-standing customer. Further, its plant-based product line includes 40 “EWG Verified” products, reflecting expertise e.l.f. is eager to tap.
Subject to the approval of a federal bankruptcy court presiding over High Ridge Brands’ Chapter 11 case, private equity firm Tengram will add a raft of personal cleansing and hair-care brands to its portfolio while bringing back former High Ridge CEO James Daniels to head up the collection’s rejuvenation.